| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/04/2008 | US20080214667 Nucleic acid molecule; complementary to a nucleotide sequence encoding a polypeptide having elongase activity |
| 09/04/2008 | US20080214666 Products and Methods Related to Mono-Methyl Branched-Chain Fatty Acids |
| 09/04/2008 | US20080214665 Novel Approach to Anti-Microbial Host Defense with Molecular Shields with Lipoxin Compounds |
| 09/04/2008 | US20080214664 Anesthetic spray composition |
| 09/04/2008 | US20080214663 Levodopa dimethyl-substituted diester prodrugs compositions, and methods of use |
| 09/04/2008 | US20080214662 Methods for the treatment of dementia based on apo e genotype |
| 09/04/2008 | US20080214661 Process To Obtain Dibenzylbutyrolactonic, Tetrahydrofuranic Lignans And Their Synthetic And Semi-Synthetic Derivatives, Their Analgesic And Anti-Inflammatory Activities, Topical And/Or Systemic Formulations Containing Said Lignans And Their Respective Therapeutic Method |
| 09/04/2008 | US20080214660 Compounds and Methods for the Inhibition of the Expression of VCAM-1 |
| 09/04/2008 | US20080214659 Stage-Specific Reduction of LUTS in Prostate Disease |
| 09/04/2008 | US20080214658 Composition Comprising Isoorientin for Suppressing Histamine |
| 09/04/2008 | US20080214657 Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice |
| 09/04/2008 | US20080214656 Compounds With Diphenoyl-Structure For the Treatment of Immune Diseases |
| 09/04/2008 | US20080214655 Paclitaxel or a paclitaxel analog and 2,5-Dimethoxythiobenzoic acid N-methylhydrazine; antitumor; nontoxic |
| 09/04/2008 | US20080214654 Substituted Benzyloxy-Phenylmethylamide Derivatives |
| 09/04/2008 | US20080214653 Methods and Compositions for the Prevention and Treatment of Kindney Disease |
| 09/04/2008 | US20080214652 Methods of treating hyperlipidemia |
| 09/04/2008 | US20080214651 Administering Atorvastatin; purer, more stable, more advantageous manufacturing properties than the amorphous product |
| 09/04/2008 | US20080214650 crystalline polymorphic dosage forms of anticholesterol agents; statins; small particle size distribution |
| 09/04/2008 | US20080214649 Compositions and Therapeutic Use of N-Acetyl Aldosamines and N-Acetylamino Acids |
| 09/04/2008 | US20080214648 Hiv Prodrugs Cleavable by Cd26 |
| 09/04/2008 | US20080214647 {1-Methyl-6-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid; thrombosis or fibrinolytic impairment is associated with formation of atherosclerotic plaques, venous and arterial thrombosis, myocardial ischemia, atrial fibrillation, deep vein thrombosis, coagulation syndromes |
| 09/04/2008 | US20080214646 Novel Nsaids Possessing a Nitric Oxide Donor Diazen-1-Ium-1,2-Diolate Moiety |
| 09/04/2008 | US20080214645 Administering 2-(1H-1-Indol-3-ylsulfanyl)benzyl]dimethyl amine; general anxiety disorder, social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks, specific phobias, social phobia and agoraphobia |
| 09/04/2008 | US20080214644 [2-(4-Fluoro-]. H-indol-3-ylsulfanyl)benzyl]dimethyl amine; depression, anxiety disorders including general anxiety disorder, social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks |
| 09/04/2008 | US20080214643 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/04/2008 | US20080214641 Chemical compounds 572 |
| 09/04/2008 | US20080214640 3'-{[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid or a salt; treatment of thrombocytopenia; may be coadministered with a colony stimulating factor, cytokine, chemokine, or an interleukin or cytokine receptor agonist or antagonist |
| 09/04/2008 | US20080214639 Leuprolide acetate and acetylcholinesterase inhibitors/NMDA receptor antagonists for the treatment of alzheimer's disease |
| 09/04/2008 | US20080214638 To treat diseases of lipid metabolism, cardiovascular disease, inflammatory diseases; selective agonists of the nicotinic acid receptor; 2-{[(4-Biphenylyloxy)acetyl]amino}-4-(methyloxy)benzoic acid |
| 09/04/2008 | US20080214637 use of catalytic amounts of organic acids to prepare losartan, irbesartan and olmesartan medoxomil or their salts, and candesartan cilexetil |
| 09/04/2008 | US20080214636 antiinflammatory, analgesic, antiallergic, cough-preventing, liver-protecting and anti-viral properties; side effects reduction; N-[(3-p-hydroxylphenyl-isoxazol-5-yl)methyl]-glycyrrhetinamide |
| 09/04/2008 | US20080214635 Modulation of pathogenicity |
| 09/04/2008 | US20080214633 (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetanilide and a carrier; diabetes, anti-obesity and anti-hyperlipemia |
| 09/04/2008 | US20080214631 Use of riluzole for the treatment of multiple sclerosis |
| 09/04/2008 | US20080214630 Desferrithiocin polyether analogues |
| 09/04/2008 | US20080214629 Administering a dosage form of 6-20 mg of tizanidine; plasma drug concentration substantially ascends over a period of 8 hours following administration |
| 09/04/2008 | US20080214628 Administering a compound (2S)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl-4-penten-2-amine; attention deficit disorder |
| 09/04/2008 | US20080214627 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex |
| 09/04/2008 | US20080214626 Methods for prevention and treatment of diseases causes by hypertension |
| 09/04/2008 | US20080214625 Administering [3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benzamide; hypertension, hyperlipidemia, hyperuricemia, gout and hypercoagulability |
| 09/04/2008 | US20080214623 N-(2,2-Dimethylpropyl)-6-{3-fluoro-5-[(3-isoxazolylamino)carbonyl]-2-methylphenyl}-3-pyridinecarboxamide; inhibitors of p38 kinase |
| 09/04/2008 | US20080214622 Substituted Triazole Derivatives As Oxytocin Antagonists |
| 09/04/2008 | US20080214621 Metabolic disorders; antidiabetic agents; obesity; hypotensive agents; antilipemic agents; 1-Cyclohexyl-3-naphthalen-2-ylmethyl-pyrrolidin-2-one |
| 09/04/2008 | US20080214620 Novel inhibitors of glutaminyl cyclase |
| 09/04/2008 | US20080214619 Business method to treat and/or prevent a gastric acid disorder with a proton pump inhibitor (PPI) and a cholinergic agonist to induce rapid onset of PPI action with or without food |
| 09/04/2008 | US20080214618 Proton pump inhibitor, a mucolytic preparation, a proton pump inhibitor in a gastrically available dosage form and a fatty acid and/or monoglyceride; gastric and/or duodenal H. pylori infections |
| 09/04/2008 | US20080214617 antitumor agents; anticancer agents; structurally related to the leptomycin family; Leptolstatin |
| 09/04/2008 | US20080214616 Pyridine Derivatives as Dipeptedyl Peptidase Inhibitors |
| 09/04/2008 | US20080214615 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
| 09/04/2008 | US20080214614 reduces intraocular pressure; primary open-angle glaucoma; effective to influence the actomyosin interactions by leading to cellular relaxation and alterations in cell-substratum adhesions |
| 09/04/2008 | US20080214613 Substituted benzimidazole compounds with dual NOS inhibitory activity and mu opioid agonist activity |
| 09/04/2008 | US20080214612 for therapy of endometriosis and/or uterine leiomyoma/leiomyomata; 1-(2-{4-[2-(4-Methanesulfonyl-phenyl)-6-methoxy-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine |
| 09/04/2008 | US20080214611 Combining an emulsion of a continuous aqueous phase and a stable dispersion of amorphous particles of a CB1 modulator of sub-micron size; 1-propanesulfonic acid, 3,3,3-trifluoro-, 4-[1-(2,4-dichlorophenyl)-3-[[(2-hydroxycyclohexyl)amino]carbonyl]-4-(hydroxymethyl)-1H-pyrazol-5-yl]phenyl ester |
| 09/04/2008 | US20080214610 Thiazolylimidazole Derivatives and Their Use as Inhibitors of Microsmal Triglyceride Transfer Protein |
| 09/04/2008 | US20080214609 compounds that agonize the membrane-associated estrogen receptor identified herein act as neuroprotectants to reduce neuronal cell death in response to ischemic stroke and inhibit reperfusion injury |
| 09/04/2008 | US20080214608 4-Amino-3,3-dimethylpiperidine; reduced toxicity, and improved pharmacology and pharmacokinetics |
| 09/04/2008 | US20080214607 Heteroaromatic quinoline compounds |
| 09/04/2008 | US20080214606 Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells |
| 09/04/2008 | US20080214605 to potentiate the effects of the other CNS agents; probes for the localization of cell surface receptors;3-(methylthio)-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide; depression, anxiety, schizophrenia, cognitive disorders, obesity, irritable bowel syndrome, emesis, pre-eclampsia, etc. |
| 09/04/2008 | US20080214604 Medicinal Composition |
| 09/04/2008 | US20080214603 5-Ht7 Receptor Antagonists |
| 09/04/2008 | US20080214602 N-Biarylamides |
| 09/04/2008 | US20080214601 2-alkylbenzoxazole carboxamides as 5ht3 modulators |
| 09/04/2008 | US20080214600 Quaternized Quinuclidine Esters |
| 09/04/2008 | US20080214599 Use of Par-1/Par-4 Inhibitors for Treating or Preventing Vascular Diseases |
| 09/04/2008 | US20080214598 Novel Piperidine Carboxylic Acid Amide Derivatives |
| 09/04/2008 | US20080214597 Tricyclic Lactam Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 09/04/2008 | US20080214596 Determining the level of expression and/or phosphorylation state of S6;rapamycin; antitumor |
| 09/04/2008 | US20080214595 Use Of Rapamycin Derivatives For The Treatment And/Or Prevention Of Cardiovas Cular Disorders |
| 09/04/2008 | US20080214594 Inhibitors Of Checkpoint Kinases |
| 09/04/2008 | US20080214593 Tetracyclic amino and carboxamido compounds and methods of use thereof |
| 09/04/2008 | US20080214592 Administering an opioid antagonist or opioid receptor partial agonist and a compound that modulates monoaminergic synaptic activity; anxiety disorder, obsessive compulsive disorder |
| 09/04/2008 | US20080214591 N-Aryl Diazaspirocyclic Compounds and Methods of Preparation and Use Thereof |
| 09/04/2008 | US20080214590 Administrating a first cytidine analogue reverse transcriptase inhibitor concurrently with deoxycytidine; increasing the antiretroviral activity of the first analogue; HIV treatment |
| 09/04/2008 | US20080214589 Thrombin Inhibiting 2,4-Dioxo-3,4-Dihydropyrimidine Derivatives |
| 09/04/2008 | US20080214588 replication inhibitors; show improved ability to inhibit the replication of mutant strains, in particular strains which show double or multiple mutations in the viral genome encoding for reverse transcriptase |
| 09/04/2008 | US20080214586 2-Amino-4-Phenylquinazoline Derivatives and the Use Thereof as Hsp90 Modulators |
| 09/04/2008 | US20080214585 For abnormal cell proliferation, inflammatory diseases, asthma, and arthritis; (S)-N-{4-[2-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-4-methylene-L-glutamic acid disodium salt (CHL1007) |
| 09/04/2008 | US20080214584 Method for treating cancer |
| 09/04/2008 | US20080214583 2-amino-4,5-dimethyl-1-(3-chlorophenyl)-1H-pyrrolo-3-carbonitrile; asthma, eczema or psoriasis |
| 09/04/2008 | US20080214582 treatment of tumors; 1-[4-(6-aminopurin-9-yl)-;phenyl]-3-[2-(pyrrolidin-3-yloxy)-5-trifluoromethylphenyl]-;urea; psoriasis, arthritis, inflammation, endometriosis, scarring, benign prostatic hyperplasia, immunological diseases, autoimmune diseases and immunodeficiency diseases |
| 09/04/2008 | US20080214581 anti-inflammatory; (2R,3S,4R,5R)-2-(2-ethyl-2H-tetrazol-5-yl)-5-[2-{[2-(1H-imidazol-4-yl)ethyl]amino}-6-({trans-4-[(2-{[2-(1H-imidazol-4-yl)ethyl]amino}-1H-purin-6-yl)amino]cyclohexyl}amino)-9H-purin-9-yl]tetrahydro-3,4-furandiol; immunosuppressive agents use in treatment of auto-immune diseases |
| 09/04/2008 | US20080214580 6-substituted 2-(benzimidazolyl)purine or purinones and 6-substituted 2-(imidazolo[4,5-c]pyridinyl)purine or purinones; Jak3 tyrosine kinase inhibitors; autoimmune and mast cell-mediated diseases, transplant rejection; antiinflammatory agents |
| 09/04/2008 | US20080214579 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/04/2008 | US20080214578 2R)-2-[(2-amino-5-{[(1S)-1-(2-fluorophenyl)ethyl]thio}[1,3]thiazolo[4,5-d]pyrimidin-7-yl)amino]pentan-1-ol; neurodegenerative disorders, demyelinating disease, cardio- and cerebrovascular atherosclerotic disorders, peripheral artery disease, rheumatoid arthritis, pulmonary diseases su COPD, asthma |
| 09/04/2008 | US20080214577 8-(3',5'-Dichlorobiphenyl-3-yl)-8-(4-methoxyphenyl)-3-(methylsulfonyl)-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amine 2.0 acetate; cognitive impairment, Alzheimer Disease, neurodegeneration and dementia |
| 09/04/2008 | US20080214576 Topoisomerase Inhibitors and Prodrugs |
| 09/04/2008 | US20080214575 Piperidine derivatives useful as ccr5 antagonists |
| 09/04/2008 | US20080214574 Inhibition of the Activity of the Capsaicin Receptor in the Treatment of Obesity or Obesity-Related Diseases and Disorders |
| 09/04/2008 | US20080214573 Compounds Useful for Inhibiting Chk1 |
| 09/04/2008 | US20080214572 Selected Tetracyclic Tetrahydrofuran Derivatives Containing a Cyclic Amine Side Chain |
| 09/04/2008 | US20080214571 e.g. 1-(3-Phenylsulfonyl-phenyl)piperazine; serotonin receptor modulator; anxiolytic agent, antidepressant, cognition activator; schizophrenia, obesity, Alzheimer's disease |
| 09/04/2008 | US20080214570 Therapeutic Agents |
| 09/04/2008 | US20080214569 Use of phosphatases to treat tumors overexpressing N-CoR |
| 09/04/2008 | US20080214568 Potentiation; overcoming drug resistance of such as candida albicans and/or aspergillus niger strains; kits |
| 09/04/2008 | US20080214567 Benzimidazole Thiophene Compounds |
| 09/04/2008 | US20080214566 Bioavailability, solubility; free drug form; schizophrenia |
| 09/04/2008 | US20080214565 Oxazolidinone Derivatives as Antimicrobials |
| 09/04/2008 | US20080214564 Macrolide compound in solid form, process for preparation thereof, and pharmaceutical composition containing the same |
| 09/04/2008 | US20080214563 Benzimidazole Thiophene Compounds As Plk Modulators |